- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/205 - Rhabdoviridae, e.g. rabies virus
Patent holdings for IPC class A61K 39/205
Total number of patents in this class: 286
10-year publication summary
|
16
|
16
|
16
|
19
|
16
|
19
|
20
|
18
|
13
|
17
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Thomas Jefferson University | 556 |
15 |
| Curevac SE | 297 |
15 |
| The University of Western Ontario | 327 |
9 |
| Intervet Inc. | 941 |
7 |
| Takeda Vaccines, Inc. | 208 |
6 |
| Wyeth LLC | 601 |
5 |
| Glaxosmithkline Biologicals S.A. | 1602 |
5 |
| Children's Hospital of Eastern Ontario Research Institute Inc. | 27 |
5 |
| Intervet International B.V. | 1337 |
5 |
| Yale University | 2569 |
5 |
| Merial Limited | 99 |
4 |
| Novavax, Inc. | 180 |
4 |
| Sanofi Pasteur SA | 56 |
4 |
| University of Georgia Research Foundation, Inc. | 1081 |
4 |
| Variation Biotechnologies, Inc. | 59 |
4 |
| Replicate Bioscience, Inc. | 46 |
4 |
| Centro de Ingenieria Genetica y Biotecnologia | 159 |
3 |
| Merial, Inc. | 209 |
3 |
| Universal Stabilization Technologies, Inc. | 17 |
3 |
| University of Massachusetts | 2341 |
3 |
| Other owners | 173 |